Position in NVO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$94,537
+$74,692 QoQ
Shares Held
1,972
+265.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,075
of 1,348 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dunhill Financial, LLC holds $6,908,274 across 15 Drug Manufacturers - General names. NVO ranks #8 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
113,506 | $2,733,224 | |
| 2 | ABBV |
AbbVie Inc.
|
4,061 | $1,021,910 | |
| 3 | JNJ |
Johnson & Johnson
|
3,664 | $930,546 | |
| 4 | LLY |
ELI LILLY & Co
|
730 | $875,583 | |
| 5 | AMGN |
Amgen Inc
|
1,716 | $621,397 | |
| 6 | NVS |
Novartis AG
|
1,303 | $204,206 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,889 | $108,844 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
1,972 | $94,537 |
All Filings in NVO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,537 | 1,972 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $19,845 | 540 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $27,475 | 540 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $59,485 | 1,072 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $94,557 | 1,370 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $62,982 | 907 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $89,546 | 1,041 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $55,843 | 469 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $22,552 | 158 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $20,287 | 158 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $14,276 | 138 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||